Recent advancements in fusion protein technologies in oncotherapy: A review

Cancer is a complicated, adaptable, and heterogeneous disease caused by a wide variety of genetic changes that might impair ability of cells to function normally. The majority of the tumors can only be shrunk using conventional oncology therapies like chemotherapy, radiation, and surgical resection,...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	International journal of biological macromolecules 2023-03, Vol.230, p.123161-123161, Article 123161
Hauptverfasser:	Mahmood, Tehreem, Shahbaz, Areej, Hussain, Nazim, Ali, Rahat, Bashir, Hamid, Rizwan, Komal
Format:	Artikel
Sprache:	eng
Schlagworte:	Antineoplastic Agents - chemistry Antineoplastic Agents - pharmacology Antineoplastic Agents - therapeutic use Cytokines Drug conjugates ELPs Fusion protein Humans Neoplasms - drug therapy Oncotherapy Peptides - chemistry Polymers - chemistry Stem cells Technology
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!